Cell & Gene Therapy Investor Forum
ATMP is at an inflection point, where significant scientific progress is now meeting increasing expectations on scalability, cost, and commercial viability. This creates a growing need for stronger alignment across the ecosystem – bringing together developers, investors, technology providers, and enabling organizations.
This joint event, hosted by CCRM Nordic and ATMP Flemmingsberg, is a dedicated investor-focused session designed to connect capital with the ATMP ecosystem. It offers a unique opportunity for investors to gain a structured understanding of the field, explore the latest developments, and engage directly with companies and experts shaping the future of cell and gene therapy.
Who should attend?
- Investors who are either new or experienced in ATMP
- Developers of ATMPs and supportive technology
Why attend?
Connect directly with leading companies and investors in the space
Get experts view of where the ATMP field is today – and where it is heading
Understand what has changed in recent years and what still remains challenging
Learn what makes an ATMP company investable
Explore technologies enabling scalability
